Last updated: June 15, 2026
Medically reviewed by: NKF Education Team
IgA nephropathy (IgAN) is the most common glomerular disease worldwide and remains a leading cause of CKD and kidney failure.
The following programs for healthcare professionals feature experts discussing the impact of IgAN on kidney health, highlighting evidence supporting treatment of the immune-mediated pathogenesis of IgAN, and reviewing the KDIGO 2025 Guideline recommendations for IgAN diagnosis and treatment.
Part 2: From the Gut to the Kidneys: How Biomarkers Are Shaping IgAN Management
Coming soon!